HCW Biologics's market cap is currently ―. The company's EPS TTM is $-0.695; its P/E ratio is -2.01; HCW Biologics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 853.10K	$ 622.81K	-	$ 1.35M	$ 1.81M
Gross Profit	$ 174.78K	$ 622.81K	$ -29.35K	$ 268.30K	$ 361.81K
EBIT	$ -4.16M	$ -4.21M	$ -4.98M	$ -5.36M	$ -4.02M
EBITDA	$ -3.89M	$ -3.92M	$ -4.68M	$ -5.10M	$ -3.86M
Net Income Common Stockholders	$ -4.94M	$ -4.30M	$ -5.07M	$ -5.41M	$ -3.91M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 11.22M	$ 17.41M	$ 28.24M	$ 32.06M	$ 26.22M
Total Assets	$ 35.62M	$ 39.48M	$ 43.53M	$ 46.81M	$ 51.35M
Total Debt	$ 6.33M	$ 6.36M	$ 6.39M	$ 6.41M	$ 6.45M
Net Debt	$ -4.89M	$ -11.05M	$ -21.85M	$ -25.65M	$ -19.78M
Total Liabilities	$ 11.75M	$ 10.90M	$ 10.92M	$ 9.38M	$ 8.80M
Stockholders Equity	$ 23.87M	$ 28.59M	$ 32.62M	$ 37.43M	$ 42.56M
Cash Flow	-
Free Cash Flow	$ -6.22M	$ -10.95M	$ -3.94M	$ -3.86M	$ -12.48M
Operating Cash Flow	$ -5.59M	$ -9.39M	$ -3.64M	$ -3.79M	$ -2.31M
Investing Cash Flow	$ 9.37M	$ -1.56M	$ -300.38K	$ -68.69K	$ 6.81M
Financing Cash Flow	$ -8.90K	$ 7.71K	$ 1.90K	$ -39.85K	$ 6.30M

Currency in USD

HCW Biologics Earnings and Revenue History

Income Statement >

HCW Biologics Debt to Assets

Balance Sheet >

HCW Biologics Cash Flow

Cash Flow >

HCW Biologics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing